Kevin Nelson

Kevin Nelson

Duane Morris LLP

Contact  |  View Bio  |  RSS

Latest Publications

Share:

FDA Requests Comments and Issues Notice of Public Hearing Related to Implementation of GDUFA

On August 19, 2014, the U.S. Food and Drug Administration (FDA) issued in the Federal Register a request for comment and notice of public hearing on a variety of topics relating to its implementation of the Generic Drug User...more

8/21/2014 - ANDA FDA GDUFA Generic Drugs Pharmaceutical Pharmaceutical Patents Prescription Drugs

ANDA Preparation (with an Eye toward Approval and Litigation) and the FDA Review

As a manufacturer of generic drug products, undoubtedly one of your goals is to prepare an Abbreviated New Drug Application (ANDA) that will pass regulatory scrutiny efficiently. Your ANDA submission is a culmination of time,...more

8/12/2014

Inch-by-Inch: FDA's New Biosimilars Guidance Inches the Industry Closer to Clinical Testing Clarity

For those under cloudy skies for two years, even a small break in the clouds would seem like a bright sunshiny day. The U.S. Food and Drug Administration's (FDA) newest draft guidance on demonstrating biosimilarity largely...more

5/16/2014 - Biosimilars Clinical Trials FDA Pharmaceutical Prescription Drugs

FDA Releases Draft Guidance on Bioequivalence Requirements for ANDA Applicants

On December 4, 2013, the U.S. Food and Drug Administration (FDA) issued a draft guidance on demonstrating bioequivalence for drugs submitted under an Abbreviated New Drug Application (ANDA). Entitled Bioequivalence Studies...more

12/6/2013

4 Results
|
View per page
Page: of 1